Pancreatic Cancer Research

ResearcherFudan UniversityNo recent work listed

Xinli Chen

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper

Papers 4

  1. Exosomes derived from immunogenically dying tumor cells as a versatile tool for vaccination against pancreatic cancer. First author DOI 10.1016/j.biomaterials.2021.121306↗
  2. Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment. Co-author DOI 10.1016/j.biomaterials.2020.120546↗
  3. Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer. Co-author DOI 10.1016/j.apsb.2019.11.013↗
  4. Codelivery Nanosystem Targeting the Deep Microenvironment of Pancreatic Cancer. Co-author DOI 10.1021/acs.nanolett.9b00374↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wenxi Zhou · 4 shared papers, 2019–2022 · strength 0.43
  2. Yu Zhou · 3 shared papers, 2020–2022 · strength 0.35
  3. Tao Sun · 3 shared papers, 2019–2022 · strength 0.32
  4. Qinjun Chen · 3 shared papers, 2019–2022 · strength 0.31
  5. Hongyi Chen · 2 shared papers, 2021–2022 · strength 0.24
  6. Chen Jiang · 2 shared papers, 2020–2021 · strength 0.23
  7. Chen Liang · 2 shared papers, 2019–2022 · strength 0.20
  8. Xianjun Yu · 2 shared papers, 2019–2022 · strength 0.20
  9. Si Shi · 2 shared papers, 2019–2022 · strength 0.20
  10. Chen Jiang · 2 shared papers, 2019–2022 · strength 0.20
  11. Yu Wang · 1 shared paper, 2022 · strength 0.12
  12. Yifan Luo · 1 shared paper, 2022 · strength 0.12
  13. Qingbing Wang · 1 shared paper, 2020 · strength 0.11
  14. Xiaoyi Ding · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.